Literature DB >> 3131537

The genetic relationships between the kringle domains of human plasminogen, prothrombin, tissue plasminogen activator, urokinase, and coagulation factor XII.

F J Castellino1, J M Beals.   

Abstract

A computer-based statistical evaluation of the optimal alignments of the kringle domains of human plasminogen, human prothrombin, human tissue plasminogen activator, human urokinase, and human coagulation Factor XIIa, as well as the putative kringle of human haptoglobin, has been performed. A variety of different alignments has been examined and scores calculated in terms of the number of standard deviations (SD) of a given match from randomness. With the exception of human haptoglobin, it was found that very high alignment scores (8.9-23.0 SD from randomness) were obtained between each of the kringles, with the kringle 1 and kringle 5 regions of human plasminogen displaying the highest similarity, and the S kringle of human prothrombin and the human Factor XII kringle showing the least similarity. The relationships obtained were employed to construct an evolutionary tree for the kringles. The predicted alignments have also allowed nucleotide mutations in these regions to be evaluated more accurately. For those regions for which nucleotide sequences are known, we have employed the maximal alignments from the protein sequences to assess nucleotide sequence similarities. It was found that a range of approximately 40-55% of the nucleotide bases were placed at identical positions in the kringles, with the highest number found in the alignment of the two kringles of human tissue plasminogen activator and the lowest number in the alignment of the S kringle of prothrombin with the second kringle of tissue plasminogen activator. From both protein and nucleotide alignments, we conclude that haptoglobin is not statistically homologous to any other kringle. Secondary structural comparisons of the kringle regions have been predicted by a combination of the Burgess and Chou-Fasman methods. In general, the kringles display a very high number of beta-turns, and very low alpha-helical contents. From analysis of the predicted structures in relationship to the functional properties of these domains, it appears as though many of their functional differences can be related to possible conformational alterations resulting from amino acid substitutions in the kringles.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3131537     DOI: 10.1007/bf02101155

Source DB:  PubMed          Journal:  J Mol Evol        ISSN: 0022-2844            Impact factor:   2.395


  23 in total

1.  Three-dimensional structure of the kringle sequence: structure of prothrombin fragment 1.

Authors:  C H Park; A Tulinsky
Journal:  Biochemistry       Date:  1986-07-15       Impact factor: 3.162

2.  Differences in the binding to fibrin of urokinase and tissue plasminogen activator.

Authors:  S Thorsen; P Glas-Greenwalt; T Astrup
Journal:  Thromb Diath Haemorrh       Date:  1972-08-31

3.  Kringles: modules specialized for protein binding. Homology of the gelatin-binding region of fibronectin with the kringle structures of proteases.

Authors:  L Patthy; M Trexler; Z Váli; L Bányai; A Váradi
Journal:  FEBS Lett       Date:  1984-06-04       Impact factor: 4.124

4.  Sequence of human haptoglobin cDNA: evidence that the alpha and beta subunits are coded by the same mRNA.

Authors:  G Raugei; G Bensi; V Colantuoni; V Romano; C Santoro; F Costanzo; R Cortese
Journal:  Nucleic Acids Res       Date:  1983-09-10       Impact factor: 16.971

5.  Localization of individual lysine-binding regions in human plasminogen and investigations on their complex-forming properties.

Authors:  P G Lerch; E E Rickli; W Lergier; D Gillessen
Journal:  Eur J Biochem       Date:  1980

6.  The primary structure of high molecular mass urokinase from human urine. The complete amino acid sequence of the A chain.

Authors:  W A Günzler; G J Steffens; F Otting; S M Kim; E Frankus; L Flohé
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1982-10

7.  Structure of the omega-aminocarboxylic acid-binding sites of human plasminogen. Arginine 70 and aspartic acid 56 are essential for binding of ligand by kringle 4.

Authors:  M Trexler; Z Váli; L Patthy
Journal:  J Biol Chem       Date:  1982-07-10       Impact factor: 5.157

8.  The binding of antifibrinolytic amino acids to kringle-4-containing fragments of plasminogen.

Authors:  K R Cole; F J Castellino
Journal:  Arch Biochem Biophys       Date:  1984-03       Impact factor: 4.013

9.  Identification and primary sequence of an unspliced human urokinase poly(A)+ RNA.

Authors:  P Verde; M P Stoppelli; P Galeffi; P Di Nocera; F Blasi
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

10.  Covalent structure of human haptoglobin: a serine protease homolog.

Authors:  A Kurosky; D R Barnett; T H Lee; B Touchstone; R E Hay; M S Arnott; B H Bowman; W M Fitch
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

View more
  8 in total

Review 1.  Bradykinin formation. Plasma and tissue pathways and cellular interactions.

Authors:  A P Kaplan; K Joseph; Y Shibayama; Y Nakazawa; B Ghebrehiwet; S Reddigari; M Silverberg
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

2.  A mutation in the kringle domain of human factor XII that causes autoinflammation, disturbs zymogen quiescence, and accelerates activation.

Authors:  Zonne L M Hofman; Chantal C Clark; Wariya Sanrattana; Aziz Nosairi; Naomi M J Parr; Minka Živkovic; Karoline Krause; Niklas A Mahnke; Jörg Scheffel; C Erik Hack; Marcus Maurer; Steven de Maat; Coen Maas
Journal:  J Biol Chem       Date:  2019-11-26       Impact factor: 5.157

3.  Engineering of a human kringle domain into agonistic and antagonistic binding proteins functioning in vitro and in vivo.

Authors:  Chang-Han Lee; Kyung-Jin Park; Eun-Sil Sung; Aeyung Kim; Ji-Da Choi; Jeong-Sun Kim; Soo-Hyun Kim; Myung-Hee Kwon; Yong-Sung Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-11       Impact factor: 11.205

4.  A phase 1, open label, dose escalation study to investigate the safety, tolerability, and pharmacokinetics of MG1102 (apolipoprotein(a) Kringle V) in patients with solid tumors.

Authors:  Gun Min Kim; Tony Reid; Sang Joon Shin; Sun Young Rha; Joong Bae Ahn; Sung Sil Lee; Hyun Cheol Chung
Journal:  Invest New Drugs       Date:  2017-03-28       Impact factor: 3.850

5.  Changes in gene expression of kringle domain-containing proteins in murine brains and neuroblastoma cells infected by prions.

Authors:  Younghwan Kim; Jihyun Song; Charles E Mays; William Titlow; Donghoon Yoon; Chongsuk Ryou
Journal:  Mol Cell Biochem       Date:  2009-03-26       Impact factor: 3.396

6.  5' control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family.

Authors:  D P Wade; J G Clarke; G E Lindahl; A C Liu; B R Zysow; K Meer; K Schwartz; R M Lawn
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

7.  Role of the kringle-like domain in glycoprotein NMB for its tumorigenic potential.

Authors:  Rudy Xie; Yukari Okita; Yumu Ichikawa; Muhammad Ali Fikry; Kim Tuyen Huynh Dam; Sophie Thi PhuongDung Tran; Mitsuyasu Kato
Journal:  Cancer Sci       Date:  2019-06-26       Impact factor: 6.716

8.  High efficacy and minimal peptide required for the anti-angiogenic and anti-hepatocarcinoma activities of plasminogen K5.

Authors:  Xia Yang; Weibin Cai; Zumin Xu; Jing Chen; Chaoyang Li; Shaojun Liu; Zhonghan Yang; Qiuhui Pan; Mingtao Li; Jianxing Ma; Guoquan Gao
Journal:  J Cell Mol Med       Date:  2010-10       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.